UT Southwestern researchers have discovered that a little-known protein, midnolin, helps cancerous B cells survive in blood cancers like leukemia and lymphoma. By mapping its structure, scientists found a way to potentially target and disable midnolin—killing up to 92% of cancer cells in lab models while sparing healthy ones.
The breakthrough could lead to more precise cancer therapies with fewer side effects.
